Success Metrics

Completion Rate
0%(0/1)
Active Trials
5(56%)
Terminated
1(11%)

Phase Distribution

Ph phase_1
1
11%
Ph phase_2
1
11%

Phase Distribution

1

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution2 total trials
Phase 1Safety & dosage
1(50.0%)
Phase 2Efficacy & side effects
1(50.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

5

trials recruiting

Total Trials

9

all time

Status Distribution
Active(6)
Terminated(1)
Other(2)

Detailed Status

Recruiting5
unknown2
Terminated1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
5
Success Rate
0.0%
Most Advanced
Phase 2

Trials by Phase

Phase 11 (50.0%)
Phase 21 (50.0%)

Trials by Status

recruiting556%
terminated111%
not_yet_recruiting111%
unknown222%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
PROCEDURE
Total Trials
9